FDA Adverse Event Malfunction Summary report: N

NC TREK CORONARY DILATATION CATHETER

MDR report key: 3080358 · Received April 26, 2013

Report

Report Number
2024168-2013-02605
Event Type
Malfunction
Date Received
April 26, 2013
Date of Event
April 9, 2013
Report Date
April 9, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
LOX
PMA / PMN Number
K110134
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR ANALYSIS AND THE REPORTED DIFFICULTY COULD NOT BE REPLICATED. BASED ON VISUAL, DIMENSIONAL AND FUNCTIONAL ANALYSIS OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THIS COMPLAINT. REVIEW OF THE COMPLAINT HISTORY OF THE REPORTED LOT DID NOT INDICATE A MANUFACTURING ISSUE. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A NON-CALCIFIED, NON-TORTUOUS LESION LOCATED IN THE PROXIMAL TO MID LEFT ANTERIOR DESCENDING ARTERY. AFTER SUCCESSFUL POST-DILATATION OF A STENT AND FULL DEFLATION OF THE 3.5 X 8 MM NC TREK BALLOON, RESISTANCE WAS FELT DURING RETRACTION OF THE BALLOON CATHETER THROUGH THE GUIDING CATHETER. AFTER RETRACTION OF THE BALLOON CATHETER, A KINK WAS OBSERVED IN THE BALLOON AREA OF THE CATHETER. THERE WAS NO REPORTED RESISTANCE DURING ADVANCEMENT OF THE BALLOON CATHETER IN THE ANATOMY. NO ADVERSE PATIENT EFFECTS OR CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE WAS REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
181231 NC TREK CORONARY DILATATION CATHETER CORONARY DILATATION CATHETER LOX AV-TEMECULA-CT 30115G2

Patients

Seq Age Sex Outcome Treatment
1 67 YR